Abstracts Archive - Page 1305 of 2607 - ACR Meeting Abstracts

Abstract Number: 1780 • 2018 ACR/ARHP Annual Meeting
Shear Wave Elastography in the Evaluation of Submandibular Gland Characteristics in IgG4-Related Disease
Keisuke Nishimura, Keiichiro Kadoba, Hiroki Mukoyama, Rintaro Saito, Daisuke Waki and Toshihiko Yokota, Department of Endocrinoligy and Rheumatology, Kurashiki Central Hospital, Kurashiki, Japan
Background/Purpose: IgG4-related disease (IgG4RD) is a chronic and systemic disease that can involve multiple organs. One of the most commonly involved organs are the salivary…
Abstract Number: 1781 • 2018 ACR/ARHP Annual Meeting
Retrospective Analysis of IgG4-RD Patient Population at the Cleveland Clinic between 2007-2017
Chan Mi Lee¹, Mohamed Alalwani², Richard Prayson^1,3 and Carmen E. Gota^1,4, ¹Education, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, ²Hospital Medicine, Cleveland Clinic, Cleveland, OH, ³Anatomic Pathology, Cleveland Clinic, Cleveland, OH, ⁴Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH
Background/Purpose: IgG4-related disease (IgG4-RD) is a rare multisystem fibro-inflammatory condition, characterized by organ mass lesions, IgG4+ lymphoplasmacytic infiltrate, and storiform fibrosis. To gain better understanding…
Abstract Number: 1782 • 2018 ACR/ARHP Annual Meeting
Cigarette Smoking Is a Risk Factor for IgG4-Related Disease
Rachel Wallwork¹, Hyon K. Choi², Cory A. Perugino³, Yuqing Zhang⁴, John H. Stone⁵ and Zachary Wallace⁶, ¹Department of Medicine, Massachusetts General Hospital, Boston, MA, ²Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, ³Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, ⁴Department of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, ⁵Rheumatology (Medicine), Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁶Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: IgG4-related disease (IgG4-RD) is a fibroinflammatory condition characterized by tumefactive lesions that can occur at nearly any site, often associated with an elevated serum…
Abstract Number: 1783 • 2018 ACR/ARHP Annual Meeting
Salivary Gland Disease in IgG4-Related Disease Is Associated with Allergic Histories
Samantha Sanders¹, Emanuel Della Torre², Cory A. Perugino³, Aidan Long⁴, Hyon K. Choi⁴, John H. Stone⁵ and Zachary Wallace⁶, ¹Harvard Medical School, Boston, MA, ²Unit of Medicine and Clinical Immunology, San Raffaele Scientific Institute, Milan, Italy, ³Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, ⁴Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, ⁵Rheumatology (Medicine), Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁶Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: The etiology of IgG4-related disease (IgG4-RD) remains unknown. The role of T-helper type 2 (Th2) cells in the pathogenesis of IgG4-RD is controversial. Given…
Abstract Number: 1784 • 2018 ACR/ARHP Annual Meeting
Serum IgG4 Test Characteristics: Immunonephelometry Versus Liquid Chromatography Tandem Mass Spectrometry
Mollie Carruthers¹, Andre Mattman², Veronika Boyeva³, Liliana Cartagena⁴, Grace van der Gugten⁵, Michael Seidman² and Luke Chen⁶, ¹Rheumatology, University of British Columbia, Vancouver, BC, Canada, ²Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada, ³Department of Medicine, University of British Columbia, Vancouver, BC, Canada, ⁴Mary Pack Arthritis Centre, Vancouver, BC, Canada, ⁵Pathology and Laboratory Medicine, St. Pauls Hospital, Vancouver, BC, Canada, ⁶Department of Hematology, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: IgG4-related disease (IgG4-RD) is a fibroinflammatory condition that may involve essentially any organ. The disease spectrum is also often associated with elevated serum IgG4,…
Abstract Number: 1785 • 2018 ACR/ARHP Annual Meeting
A Data-Driven Approach to Guide Physicians When Considering the Differential Diagnosis of IgG4-Related Disease
Mark A. Matza¹, Zachary Wallace² and John H. Stone³, ¹Rheumatology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ²Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³Rheumatology (Medicine), Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: IgG4-Related Disease (IgG4-RD) is a chronic immune-mediated fibro-inflammatory disorder of unknown etiology. The differential diagnosis is broad, partly because of the myriad potential organ…
Abstract Number: 1786 • 2018 ACR/ARHP Annual Meeting
Favourable Response to Rituximab for the Treatment of IgG4-Related Disease: Long-Term Follow-up of 10 Patients Resistant to Glucocorticoids and Immunosuppressives
Emin Oguz¹, Gizem Dagcı², Murat Erdugan¹, Bahar Artim-Esen¹, Ahmet Gül¹, Lale Ocal¹ and Murat Inanc³, ¹Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ²Department of Internal Medicine, Istanbul Unıversity, Istanbul Faculty of Medicine, Istanbul, Turkey, ³Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, İstanbul, Turkey
Background/Purpose: Immunoglobulin G4-related disease (IgG4-RD) is a systemic, immuno-mediated fibro-inflammatory disease that affects various organ systems, with typical pathological findings and increased IgG4 levels. Glucocorticoids…
Abstract Number: 1787 • 2018 ACR/ARHP Annual Meeting
How to Better Diagnose IgG4 Related Disease: a Single-Center Based Experience
Anji Xiong¹, Yuan Yang¹, Beibei Cui¹, Jianhong Sun¹, Qibing Xie¹, Yi Zhao¹, Chunyu Tan¹, Min Yang¹, Yi Liu¹, Honghu Tang¹, Pingying Qing¹, Lingshu Zhang¹, Yubin Luo¹, Yan Liang¹, Ying Wang¹, Yali Ye¹, Ling Ma¹, Shiyu Yi¹ and Yi Liu², ¹Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China, ²Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Chengdu, China
Background/Purpose: Pathology associated with IgG4-related disease (IgG4-RD) has been described in virtually every tissue and organ of the body. The heterogeneous clinical manifestations of IgG4-RD…
Abstract Number: 1788 • 2018 ACR/ARHP Annual Meeting
Predictive Factors for Work-Day Loss in a Multi-Center Study in Behcet’s Disease: Indirect Costs for Healthcare
Haner Direskeneli, Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Background/Purpose: In chronic diseases, work-day loss due to health problems is associated with indirect costs for healthcare management. The aim of this multi-center study is…
Abstract Number: 1789 • 2018 ACR/ARHP Annual Meeting
Mucocutaneous Activity Index As a Patient-Reported Outcome Measure in Behcet’s Disease: A Multi-Center Study from Turkey
Haner Direskeneli, Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Background/Purpose: Organ-specific patient-reported outcome (PRO) measures may help management decisions of Behcet’s disease (BD). The aim of this prospective study was to evaluate the factors…
Abstract Number: 1790 • 2018 ACR/ARHP Annual Meeting
An Unmet Need for Oral Ulcer Activity in Patients with Behcet’s Disease: A Multi-National Study
Gonca Mumcu¹, Adebowale Adesanya², Aysun Aksoy³, Joice Moraes Faria M Belem⁴, Natalia Borges Cardin⁴, Fatma Alibaz-Oner⁵, Tulin Ergun⁶, Nevsun Inanc⁷, Alexandre W.S. Souza⁸, Wafa Madanat⁹, Farida Fortune¹⁰ and Haner Direskeneli⁷, ¹Department of Health Management, Marmara University, Faculty of Health Sciences, Istanbul, Turkey, ²Barts and The London, School of Medicine and Dentistry, Institute of Dentistry, Clinical and Diagnostic Oral Sciences, London, UK, London, United Kingdom, ³Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, ⁴Rheumatology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil, ⁵Şerifali mahallesi İbrahim Hakkı sokak. Lavella 4 sitesi. B blok, D:22 Umraniye, Şerifali mahallesi İbrahim Hakkı sokak. Lavella 4 sitesi. B blok, D:22 Umraniye, Istanbul, Turkey, ⁶Department of Dermatology, Faculty of Medicine, Marmara University, Istanbul, Turkey, ⁷Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, ⁸Rheumatology Division, Universidade Federal de São Paulo, Sao Paulo, Brazil, ⁹Jordan’s Friends of Behcet’s disease Patients Society, Medical department, Amman, Jordan, Amman, Jordan, ¹⁰Dental Institute, Barts and The London NHS Trust, London, United Kingdom
Background/Purpose: Efficacy of current management approaches for oral ulcer treatment in routine clinical practice is insufficiently explored in Behcet’s disease (BD) patients. The aim of…
Abstract Number: 1791 • 2018 ACR/ARHP Annual Meeting
Efficacy of Apremilast for Oral Ulcers Associated with Active Behçet’s Syndrome in a Phase III Study: A Prespecified Analysis By Baseline Patient Demographics and Disease Characteristics
Gulen Hatemi¹, Alfred Mahr², Mitsuhiro Takeno³, Do-Young Kim⁴, Melike Melikoglu¹, Sue Cheng⁵, Shannon McCue⁵, Maria Paris⁵, Mindy Chen⁵ and Yusuf Yazici⁶, ¹Istanbul University Cerrahpasa Medical School, Istanbul, Turkey, ²Hospital Saint-Louis, University Paris Diderot, Paris, France, ³Nippon Medical School Graduate School of Medicine, Tokyo, Japan, ⁴Yonsei University College of Medicine and Severance Hospital, Seoul, Korea, Republic of (South), ⁵Celgene Corporation, Summit, NJ, ⁶New York University School of Medicine, New York, NY
Background/Purpose: Behçet’s syndrome is a chronic, multi-system inflammatory disorder characterized by recurrent oral ulcers (OU) that can be disabling and negatively affect quality of life.…
Abstract Number: 1792 • 2018 ACR/ARHP Annual Meeting
Work Productivity Is Impaired in Patients with Behcet’s Syndrome
Nergis Serin¹, Yesim Ozguler¹, Sinem Nihal Esatoglu¹, Vedat Hamuryudan¹ and Gulen Hatemi², ¹Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ²Istanbul University Cerrahpasa Medical School, Istanbul, Turkey
Background/Purpose: Behcet’s syndrome (BS) is most active during young adulthood and working years, thus affecting productivity. Work disability was previously reported especially among BS patients…
Abstract Number: 1793 • 2018 ACR/ARHP Annual Meeting
The Omeract Core Domain Set for Clinical Trials in Behçet’s Syndrome
Gulen Hatemi¹, Alexa Meara², Yesim Ozguler³, Haner Direskeneli⁴, Alfred Mahr⁵, Beverly Shea⁶, Esen Cam⁷, Ahmet Gül⁸, Yusuf Yazici⁹, Peter Tugwell¹⁰, Hasan Yazici¹¹ and Peter A. Merkel¹², ¹Istanbul University Cerrahpasa Medical School, Istanbul, Turkey, ²Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, ³Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ⁴Rheumatology, Marmara University, School of Medicine Hospital, Istabul, Turkey, ⁵Hôpital Saint-Louis (Hôpitaux Universitaires Saint-Louis), Paris, France, ⁶Bruyere Research Institute, Ottawa, ON, Canada, ⁷The Univeristy of Istanbul, Istanbul, Turkey, ⁸Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, ⁹New York University School of Medicine, New York, NY, ¹⁰Center For Global Health, Institute of Population Hlth, Ottawa, ON, Canada, ¹¹Division of Rheumatology,, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ¹²Division of Rheumatology and the Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA
Background/Purpose: There is an unmet need for reliable, validated, and widely-accepted outcome measures for clinical trials in Behçet’s syndrome (BS). The Outcome Measures in Rheumatology…
Abstract Number: 1794 • 2018 ACR/ARHP Annual Meeting
Venous Vessel Wall Thickness in Lower Extremity Is Increased in Male Behcet’s Disease Patients
Fatma Alibaz-Oner¹, Rabia Ergelen², Aydan Mutiş³, Zeynep Erturk¹, Ruslan Asadov⁴, Tulin Ergun⁵ and Haner Direskeneli⁶, ¹Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, ²Marmara University School of Medicine, Radiology, ISTANBUL, Turkey, ³Marmara University, School of Medicine, Rheumatology, ISTANBUL, Turkey, ⁴Marmara University School of Medicine, Radiology, Istanbul, Turkey, ⁵Marmara University, School of Medicine, Dermatology, Istanbul, Turkey, ⁶Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Background/Purpose: Vascular involvement is seen in up to 40% of the patients with Behcet's Disease (BD), especially in young males and is one of the…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].